 鲜花( 85)  鸡蛋( 2)
|
楼主 |
发表于 2015-2-28 21:48
|
显示全部楼层
Stock soars after Cold-fX wins crucial approval5 S+ Q" s8 l. E" [8 o# k
( M& @/ i3 S0 }+ J# g3 M
EDMONTON - CV Technologies Inc. shares rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.
5 C# Z7 r0 ~* ^: B; v# @2 a
( k3 S6 y/ x6 o$ F- r- \/ `BY THE EDMONTON JOURNAL FEBRUARY 16, 2007
. Y* i1 q2 J3 h& ^ & T+ M& M3 m3 w# Y/ U" D$ t4 S5 ^
# v% e" u0 ? h& G4 }8 REDMONTON - CV Technologies Inc. SHARES rose nearly 60 per cent Thursday after Health Canada approved the claims at the core of the company's marketing of its cold and flu drug Cold-fX.5 [& t8 @8 w- ?0 R- B
+ x" ` k2 H+ i/ P6 n; gThe agency said CV Technologies can continue to market Cold-fX as helping "to reduce the frequency, severity and duration of cold and flu symptoms by boosting the IMMUNE SYSTEM."4 h* Z. @! a0 T7 \: u
; j% w6 @7 S1 u+ nThe APPROVAL follows a review of seven clinical trials and more than 10 years of research about the product.
L [7 ^! s* b2 `" i: Y C
5 P, Z2 `: g3 f# t7 z9 c3 XIt should create even more confidence among consumers and medical professionals that the product works, CEO Jacqueline Shan said Thursday.
1 ]1 ~& t: E8 K; r* Z, y' W w; b9 a1 Q/ V9 {
It certainly instilled confidence in the market, as shares closed at $2.90 on THE TORONTO STOCK EXCHANGE, up $1.08 on a volume of 4.6 million.
. a) n- a5 C/ c/ k, A. \
6 M* O. T$ P" C/ I, m"As a scientist, it's one of the highlights of my CAREER," Shan said. ?/ l4 A6 {: G: I6 y9 \7 j
3 A$ h/ m; j, V0 {* n7 ^! a
"This approval is a breakthrough in realizing our vision of being a global leader in developing products for disease prevention."
' I, |% K4 }( v& f& q' h* E+ Q& B3 O# x1 \8 N* _5 ` `
It's Cold-fX's strongest medical recognition to date, said Shan. It means the company can advertise the HEALTH BENEFITS more effectively to consumers and health professionals, she said.; N: m/ Y/ C; p
# P; ? e) f) E: X% }, @9 F# l
Ginseng-based Cold-fX is already the top-selling cold and flu treatment in Canada, but Shan said there is plenty of room for more growth.
( s! `! { f0 ]# h; F
. p) J) Y1 ], ~$ D" \The approval will also help raise the product's PROFILE in the lucrative U.S. market, which Cold-fX entered in October. The move came with a new marketing push, using former Oilers superstar Mark Messier as its spokesman./ i$ B& W( z. F) ]
4 ?: A3 ?- j' e
7 }9 } n3 y r f& I* C' f9 Fhttp://www.canada.com/story.html ... 9-be80-f40f1426f662 |
|
狗仔卡
发表于 2015-2-28 18:25
提升卡
置顶卡
沉默卡
喧嚣卡
变色卡
显身卡
; p$ U0 o# B3 k8 m E: n
发表于 2015-2-28 19:45
